We are live on ! Find out more
NHC

Nicholas Hoffman & Company Portfolio holdings

AUM $4.33B
1-Year Est. Return 18.98%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+18.98%
3 Year Est. Return
+55.21%
5 Year Est. Return
+46.72%
10 Year Est. Return
+185.29%
AUM
$2.13B
AUM Growth
+$162M
Cap. Flow
+$135M
Cap. Flow %
6.32%
Top 10 Hldgs %
74.03%
Holding
303
New
12
Increased
145
Reduced
81
Closed
18

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$1.04M
2
CVS icon
CVS Health
CVS
+$650K
3
CIVB icon
Civista Bancshares
CIVB
+$555K
4
MMM icon
3M
MMM
+$392K
5
UL icon
Unilever
UL
+$357K

Sector Composition

Rank Sector Weight
1 Technology 7.84%
2 Financials 7.12%
3 Consumer Staples 1.93%
4 Healthcare 1.77%
5 Consumer Discretionary 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWD icon
226
iShares Russell 1000 Value ETF
IWD
$81.4B
$341K 0.02%
1,953
-98
-5% -$17.1K
CB icon
227
Chubb
CB
$140B
$338K 0.02%
+1,326
New +$341K
PDCO
228
DELISTED
Patterson Companies, Inc.
PDCO
$335K 0.02%
+13,905
New +$348K
BSV icon
229
Vanguard Short-Term Bond ETF
BSV
$44.7B
$335K 0.02%
+4,365
New +$333K
VONV icon
230
Vanguard Russell 1000 Value ETF
VONV
$20.5B
$325K 0.02%
4,247
RY icon
231
Royal Bank of Canada
RY
$287B
$325K 0.02%
3,051
TM icon
232
Toyota
TM
$228B
$324K 0.02%
1,580
-17
-1% -$3.76K
HDV
233
iShares Core High Dividend ETF
HDV
$14.7B
$324K 0.02%
14,890
+65
+0.4% +$1.42K
HCA icon
234
HCA Healthcare
HCA
$88.4B
$321K 0.02%
1,000
TSN icon
235
Tyson Foods
TSN
$21.5B
$321K 0.02%
5,610
NEE icon
236
NextEra Energy
NEE
$185B
$319K 0.02%
4,507
+409
+10% +$29K
IEMG icon
237
iShares Core MSCI Emerging Markets ETF
IEMG
$144B
$313K 0.01%
5,839
+542
+10% +$28.6K
GMF icon
238
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$410M
$311K 0.01%
2,793
+11
+0.4% +$1.19K
DEO icon
239
Diageo
DEO
$49.6B
$302K 0.01%
2,395
+183
+8% +$25.2K
NKE icon
240
Nike
NKE
$64.1B
$301K 0.01%
3,996
-64
-2% -$5.95K
GILD icon
241
Gilead Sciences
GILD
$165B
$301K 0.01%
+4,387
New +$293K
LHX icon
242
L3Harris
LHX
$55.4B
$294K 0.01%
1,310
+5
+0.4% +$1.08K
MAR icon
243
Marriott International
MAR
$100B
$292K 0.01%
1,207
+2
+0.2% +$480
IEFA icon
244
iShares Core MSCI EAFE ETF
IEFA
$186B
$290K 0.01%
3,993
+6
+0.2% +$442
RF icon
245
Regions Financial
RF
$26.4B
$289K 0.01%
14,424
-1,000
-6% -$19.4K
JCI icon
246
Johnson Controls International
JCI
$85.1B
$287K 0.01%
4,314
PJP icon
247
Invesco Pharmaceuticals ETF
PJP
$445M
$286K 0.01%
3,475
ROP icon
248
Roper Technologies
ROP
$40.4B
$285K 0.01%
505
+2
+0.4% +$1.08K
MHK icon
249
Mohawk Industries
MHK
$6.91B
$284K 0.01%
2,500
BN icon
250
Brookfield
BN
$102B
$282K 0.01%
10,172
+386
+4% +$10.8K

Similar funds

Nicholas Hoffman & Company's Q2 2024 Portfolio in Review

As of Q2 2024, Nicholas Hoffman & Company held 303 positions worth $2.13B, up 8.2% from $1.97B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Nicholas Hoffman & Company deployed $135M of net new capital in Q2 2024, opening 12 new positions and adding to 145 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.7% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Accenture, an estimated $1.04M trimmed.

  • Nicholas Hoffman & Company's largest Q2 2024 buy was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.
  • Nicholas Hoffman & Company added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $41.8M increase.
  • Nicholas Hoffman & Company's biggest Q2 2024 reduction was Accenture, cutting an estimated $1.04M.
  • Nicholas Hoffman & Company fully exited CVS Health in Q2 2024, selling an estimated $650K.
  • Nicholas Hoffman & Company's ten largest holdings make up 74% of its $2.13B portfolio in Q2 2024.
  • Nicholas Hoffman & Company opened 12 new positions and closed 18 in Q2 2024.
  • Nicholas Hoffman & Company's portfolio value rose 8.2% quarter-over-quarter to $2.13B.

Based on Nicholas Hoffman & Company's 13F filing for Q2 2024, filed 2 Aug 2024.